Abstract
Purpose
To corroborate the vascular etiology of sudden sensorineural hearing loss (SNHL) utilizing magnetic resonance imaging (MRI).
Patient
A 24-year-old male with a history of sickle cell disease experienced sudden SNHL and right horizontal nystagmus, without accompanying vertigo.
Intervention
Audiometric evaluation revealed left-sided SNHL, predominantly affecting high frequencies. Video head impulse testing demonstrated isolated dysfunction of the left posterior semicircular canal. An urgent brain MRI identified a recent punctiform ischemic stroke in the frontal region. A subsequent MRI, conducted with a 4-hour delay and post-contrast enhancement, highlighted a hyperintense signal within the left cochlear region and the left posterior semicircular canal.
Conclusion
The investigative results substantiate an infarction in the territory of the cochlear artery, precipitated by a vaso-occlusive event, thereby reinforcing the vascular hypothesis of cochleovestibular artery syndrome. This case underscores the congruence between clinical observations and delayed post-contrast MRI findings.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Objective
To present a case of sudden sensorineural hearing loss (SNHL) where a delayed post-contrast magnetic resonance imaging (MRI) with high-resolution 3D fluid-attenuated inversion recovery (FLAIR), performed 4 h post-injection, morphologically substantiated the instrumental and audiological findings indicative of an infarction in the cochlear artery territory.
Patient
This report details a 24-year-old male with sickle cell disease due to compound heterozygous SC, exhibiting 46% hemoglobin C and 8.9% G6PD-free fetal hemoglobin. His medical history is notable for a singular vaso-occlusive episode six years prior, which was complicated by medullary necrosis. Additionally, he has been diagnosed with sickle cell retinopathy and has an aneurysmal bone cyst of the humerus. This patient had only undergone a single transfusion episode and was neither followed up nor managed at our hospital for their sickle cell disease.
Diagnostic
The patient presented at the emergency department with a 24-hour history of acute onset deafness and tinnitus of the left ear. There were no accompanying vestibular or neurological symptoms reported. Videonystagmography revealed right horizontal nystagmus, elicited by high-frequency skull-vibration (100 Hz). Halmagyi’s sign was negative. Otoscopy was normal. The tuning fork examination indicated sensorineural hearing loss in the left ear.
The patient had no other neurological signs, with a Glasgow Coma Scale score of 15, no headache, no decrease in visual acuity, no focal signs, no sensorimotor deficit, no peripheral facial paralysis, no cerebellar syndrome, and no pyramidal syndrome.
Pure tone audiometry (PTA) confirms a left SNHL (Fig. 1).
Laboratory investigations revealed a hemoglobin level of 13.1 g/dL, a platelet count of 497.109/L (normal range: 150–400), and elevated lactate dehydrogenase (LDH) at 301 U/L (normal range: 135–225 U/L), with no electrolyte imbalances detected.
Due to the increased risk of arterial occlusion associated with sickle cell disease, cerebral MRI was conducted to rule out occlusive events within the territory of the anterior inferior cerebellar artery (AICA) or other potential ischemic lesions. The 1.5 Tesla MRI (Ingenia 1.5T MRI, Philips Healthcare, Best, The Netherlands) did not reveal ischemic lesions in the AICA territory; however, it did demonstrate a recent punctiform ischemic stroke in the left frontal area (Fig. 2). Vascular integrity within the cerebral vasculature and internal auditory canal was verified. There was no hypersignal of the labyrinth on the standard FLAIR sequences.
Following neurologic consultation, aspirin therapy at a dosage of 75 mg daily was initiated for the management of the ischemic stroke.
A 1.5 Tesla MRI of the ears was conducted 48 h post-symptom onset, with 3D High-Resolution (HR) DRIVE and 3D FLAIR HR sequences, 4 h after intravenous administration of gadolinium contrast (Dotarem 20 mL, Guerbet, Villepinte, France). The imaging revealed hyperintensity in the left cochlea and left posterior semicircular canal (SSC) on the 3D FLAIR sequence. Additionally, a subtle discontinuity in the fluid signal was observed at the inferior aspect of the posterior SSC arch on the 3D DRIVE sequence (Fig. 3).
1.5 Tesla MRI performed 4 h post-intravenous gadolinium injection revealed hyperintensity within the left cochlea and posterior semicircular canal (arrows) on 3D FLAIR imaging (A) (B), and a minor fluid amputation from the left posterior semicircular canal (arrow) visualized on 3D DRIVE imaging reconstruction in the axis of the canal (C)
A video-Head-Impulse-Test (vHIT) (ICS Impulse, Otometrics, Taastrup, Denmark) was performed, confirming the isolated functional impairment of the left posterior SCC (Fig. 4).
The diagnosis of sudden unilateral SNHL by acute occlusion of the cochlear artery was therefore confirmed instrumentally (PTA and vHIT) and morphologically (3T MRI).
Intervention
Corticosteroid therapy was not initially proposed as it carries the risk of exacerbating the hyperviscosity syndrome and causing a severe vaso-occlusive crisis. Therapeutic phlebotomy was initiated in the emergency department, aiming to reduce hemoglobin levels to below 11.5 g/dL. This objective was achieved following the removal of 650 mL of blood (450 mL on the first day and 200 mL on the second day). The main objective of the phlebotomies was primarily to prevent further organ damage from this vaso-occlusive crisis. There were no adverse effects from these phlebotomies.
Discharge home was authorized on day 2 with auditory rest recommended, and a 10-day corticosteroid therapy (prednisolone 120 mg daily).
Following audiometric assessments on the 7th and the 11th days post-treatment initiation stable auditory thresholds were observed. A supplementary treatment of five trans-tympanic injections of Dexamethasone 4 mg/mL spaced 48 h was executed. Audiometric evaluation after injection at the first and the 7th month revealed normalization of low frequency and very slight improvement of high frequency (Fig. 1). vHIT at the 7th month showed no improvement compared to the initial one. A hearing aid was proposed approximately 7 months after the episode. However, the patient did not wish to procure it.
Discussion
The relationship between sickle cell disease and hearing loss has been clearly documented (between 12 and 66% among individuals with sickle cell disease), and most of the cases have progressive bilateral hearing loss (progressive cochlear damage by hypoxia stemming from the sickle shape of the red cells) [1].
Sickle cell disease is also recognized as a contributing factor to sudden SNHL, with a reported incidence of 2.2% among pediatric cases [2, 3]. In cases of sudden bilateral sensorineural hearing loss, expeditious cochlear implantation is advocated in sickle cell patients, owing to the heightened risk of precipitous cochlear sclerosis [4]. In the general population, the etiologies of sudden SNHL are markedly heterogeneous and frequently elusive; idiopathic sudden sensorineural hearing loss is the predominant diagnosis [5,6,7]. In individuals with sickle cell disease, sudden SNHL is predominantly attributed to vaso-occlusive crises. As early as the 1970s, Berry reported the presence of sensorineural hearing loss in sickle cell patients, noting that hearing loss in the high frequencies may quite possibly be related to cochlear thrombosis in microcirculations [8].
Regarding the patient in question, it is substantiated that the individual experienced a vaso-occlusive crisis, which is further corroborated by the occurrence of a concomitant frontal cerebral infarction. The crisis likely involved the common cochlear artery, which supplies the cochlea and the posterior semicircular canal [7, 9].
This assertion is supported by clinical instrumental findings, including auditory impairment in PTA and isolated dysfunction of the posterior semicircular canal as assessed by vHIT, and by radiological (MRI) evidence indicating the involvement of the posterior semicircular canal and cochlea.
Furthermore, the utilization of delayed post-contrast MRI of the inner ear using 3D FLAIR HR sequences is being refined for the in vivo delineation of endolymphatic and perilymphatic fluids [10]. This diagnostic modality has demonstrated utility in the diagnosis of hydropic ear diseases [11, 12] and their auditory sequelae, albeit certain images may present interpretative challenges.
In emergency presentations of sudden SNHL with a strong suspicion of vascular etiology, this imaging technique permits the in vivo examination of inner ear fluids during the crisis. This could provide invaluable insights into the pathophysiological underpinnings of sudden SNHL and its etiological assessment.
In the present case, the clinical-radiological congruence is particularly evident, reinforcing the notion that delayed post-contrast MRI with 3D FLAIR HR sequence is capable of illustrationg the repercussions of localized arterial occlusion within the inner ear. Additionally, Eliezer et al. have documented an analogous presentation in a 60-year-old female patient with rheumatoid arthritis [13]. This case is differentiated by the hematologic pathology of the subject, bolstering the vascular etiology for what they have termed “Cochleovestibular artery syndrome”.
The absence of vertigo reported by the patient can be explained by the limited involvement of the posterior labyrinth (only the posterior semicircular canal), the lower gain of the posterior semicircular canal compared to the lateral canal, its non-alignment with the axis of head rotation, and the patient’s focus on his hearing loss which may have led to overlooking any added sensation of vertigo.
The right horizontal vibratory nystagmus indicates vestibular asymmetry affecting the left labyrinth. Despite no evidence of lateral canal involvement at high frequencies (vHIT), it may exist at very high frequencies (vibration-induced nystagmus). Cochlear ischemia also explain vestibular asymmetry by impairing the blood-labyrinth barrier and the stria vascularis, disrupting the endolymph (ionic, pressure, potential) balance, which affects all labyrinthine structures [14, 15].
Conclusion
This clinical case elucidates several pivotal insights. Primarily, sudden SNHL, notably in an individual with sickle cell disease, mandates prompt cerebrovascular evaluation via brain MRI to rule out stroke during a vaso-occlusive crisis. Moreover, there is a discernible clinical-radiological congruity between the PTA-VHIT duo and the delayed post-contrast MRI of the inner ears utilizing a 3D FLAIR HR sequence in the acute arterial occlusion of the cochlear artery. This alignment furnishes novel avenues for the application of this imaging modality in the diagnostic process of sudden SNHL.
References
Da Silva LPA, Nova CV, Lucena R (2012) Sickle cell anemia and hearing loss among children and youngsters: literature review. Braz J Otorhinolaryngol 78:126–131. https://doi.org/10.1590/S1808-86942012000100020
O’Keeffe L (1993) Sudden sensorineural hearing loss in sickle cell disease. J Laryngol Otol 107(12):1195. https://doi.org/10.1017/s0022215100125654
Bois E, Francois M, Benkerrou M, Van Den Abbeele T, Teissier N (2019) Hearing loss in children with sickle cell disease: a prospective French cohort study. Pediatr Blood Cancer 66(1):e27468. https://doi.org/10.1002/pbc.27468
Kim SJ, Taheri MR, Merkison M, Monfared A (2018) Cochlear implantation in a patient with Sickle Cell Disease with Early Cochlear Sclerosis. Otol Neurotol 39(2):e87–e89. https://doi.org/10.1097/MAO.0000000000001660
Plontke SK (2018) Diagnostics and therapy of sudden hearing loss. GMS Curr Top Otorhinolaryngol Head Neck Surg 16:Doc05. https://doi.org/10.3205/cto000144
Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC (2011) Sudden Sensorineural hearing loss. Trends Amplif 15(3):91–105. https://doi.org/10.1177/1084713811408349
Yoon TH, Paparella MM, Schachern PA, Alleva M (1990) Histopathology of sudden hearing loss. Laryngoscope 100(7):707–715. https://doi.org/10.1288/00005537-199007000-00006
Mazzoni A (1990) The vascular anatomy of the vestibular labyrinth in man. Acta Otolaryngol Suppl 472:1–83. https://doi.org/10.3109/00016489009121137
Berry RA (1975) Sickle cell anemia: audiological findings. J Am Audiol Soc 1:61–63
Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T (2012) Imaging of Menière’s Disease after Intravenous Administration of single-dose Gadodiamide: utility of subtraction images with different Inversion Time. Magn Reson Med Sci 1(3):213–219. https://doi.org/10.2463/mrms.11.213
Nakashima T, Pyykkö I, Arroll MA, Casselbrant ML, Foster CA, Manzoor NF, Megerian CA, Naganawa S, Young YH (2016) Meniere’s disease. Nat Rev Dis Primers 2:16028. https://doi.org/10.1038/nrdp.2016.28
Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, Nakata S, Katayama N, Ishida IM (2007) Visualization of endolymphatic Hydrops in patients with Meniere’s Disease. Laryngoscope 117(3):415–420. https://doi.org/10.1097/MLG.0b013e31802c300c
Eliezer M, Toupet M, Guichard JP, Kania R, Houdart E, Hautefort C (2019) Cochleovestibular artery syndrome: consideration based on VHIT, VEMP, and inner ear MRI. J Neurol 266(9):2327–2329. https://doi.org/10.1007/s00415-019-09407-9
Thulasiram MR, Ogier JM, Dabdoub A (2022) Hearing function, degeneration, and Disease: spotlight on the Stria Vascularis. Front Cell Dev Biol 10:841708. https://doi.org/10.3389/fcell.2022.841708
Johns JD, Adadey SM, Hoa M (2023) The role of the stria vascularis in neglected otologic disease. Hear Res 428:108682. https://doi.org/10.1016/j.heares.2022.108682
Funding
Open access funding provided by Centre Hospitalier Universitaire de Lille.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Risoud, M., Toulemonde, P., Beck, C. et al. MRI-confirmed cochlear artery infarct clinically diagnosed in a patient with sickle cell disease: a case report. Eur Arch Otorhinolaryngol (2024). https://doi.org/10.1007/s00405-024-08837-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00405-024-08837-0